A Study of Brenipatide in Participants With Alcohol Use Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 am - 8 pm Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
117 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anima Research
Diepenbeek, Belgium
Erik BuntinxRecruiting - Kormont
Kluisbergen, Belgium
Klaas VercruysseRecruiting - Gezondheidshuis de Gloed
Machelen, Belgium
Klaas VercruysseRecruiting - Meclinas
Mechelen, Belgium
Claudia CornelisRecruiting - Medisch Centrum Saffrou
Oudenaarde, Belgium
Klaas VercruysseRecruiting
- Beijing Anding Hospital - Affiliated Capital University of Medical Science
Beijing, China
Xiaomeng XingRecruiting - Beijing Huilongguan Hospital
Beijing, China
Yunlong TanRecruiting - the Second People'S Hospital of Hunan Province
Changsha, China
Xuhui ZhouRecruiting - the Second Xiangya Hospital of Central South University
Changsha, China
Wei HaoRecruiting - West China Hospital, Sichuan University
Cheng Du Shi, China
Jing LiRecruiting - the Fourth People'S Hospital of Chengdu
Chengdu, China
Xi TanRecruiting - Guangzhou Brain Hospital
Guangzhou, China
Ni FanRecruiting - Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Hangzhou, China
Jinsong TangRecruiting - the Seventh People'S Hospital of Hangzhou
Hangzhou, China
Wanjun GuoRecruiting - Zhejiang Provincial People'S Hospital
Hangzhou, China
Zhengluan LiaoRecruiting - the Fourth Hospital of Harbin Medical University
Harbin, China
Leijing ZhangRecruiting - Hefei No.4 People'S Hospital
Hefei, China
Liangjun PangRecruiting - Huzhou Third Municipal Hospital
Huzhou, China
Mincai QianRecruiting - Shandong Mental Health Center
Jinan, China
Wei YuanRecruiting - First Affiliated Hospital of Kunming Medical University
Kunming, China
Jin LuRecruiting - the Affilicated Kangning Hospital of Ningbo University
Ningbo, China
Haihang YuRecruiting - Shanghai Mental Health Center
Shanghai, China
Jiang DuRecruiting - Shenzhen Kangning Hospital
Shenzhen, China
Mei YangRecruiting - the First Hospital of Hebei Medical University
Shijiazhuang, China
Qifeng ZhuRecruiting - the Affiliated Hospital of Southwest Medical University
Sichuan, China
Kezhi LiuRecruiting - Wuhu Hospital of Beijing Anding Hospital
Wuhu, China
Changqing HuRecruiting - Xi An Mental Health Center
Xi'an, China
Guibin LiRecruiting - Xiamen Xianyue Hospital
Xiamen, China
Yan QiuRecruiting - Xianyang Hospital of Yan'An University
Xianyang, China
Aihong GuoRecruiting - Psychiatric Hospital of Henan Province
Xinxiang, China
Dan WangRecruiting - Zhenjiang Mental Health Center
Zhenjiang, China
Zhoubing WangRecruiting - Zhumadian Psychiatric Hospital
Zhumadian, China
Chong WangRecruiting
- Futuremeds Gmbh
Berlin, Germany
Peter HahnRecruiting - Velocity Clinical Research, Berlin
Berlin, Germany
Isabelle SchenkenbergerRecruiting - Klinische Forschung Dresden
Dresden, Germany
Peter HeymerRecruiting - Klinische Forschung Hamburg
Hamburg, Germany
Christian DeckertRecruiting - Zentralinstitut Für Seelische Gesundheit
Mannheim, Germany
Patrick BachRecruiting - Dedicated Research Site Futuremeds
Offenbach, Germany
Florieke BerfeloRecruiting - Klinische Forschung Schwerin Gmbh
Schwerin, Germany
Christine PaschenRecruiting
- Tokyo-Eki Center-Building Clinic
Chūōku, Japan
Arihiro KiyosueRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Oct 2025
- Primary completion
- 30 Apr 2028
- Completion
- 30 Apr 2028
- Last update posted
- 7 Jul 2026
- Registered enrollment
- 1,100
- Registry id
- NCT07219953
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.